3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)-

3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- manufacturers

  • DHODH-IN-19
  • DHODH-IN-19 pictures
  • $2140.00
  • 2026-04-20
  • CAS:2742675-85-8
  • Purity:
  • Supply Ability: 10g
3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- Basic information
Product Name:3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)-
Synonyms:3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)-;DHODH-IN-19
CAS:2742675-85-8
MF:C22H18ClF6N3O3
MW:521.84
EINECS:
Product Categories:
Mol File:2742675-85-8.mol
3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- Structure
3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- Chemical Properties
Boiling point 541.3±60.0 °C(Predicted)
density 1.45±0.1 g/cm3(Predicted)
pka13.54±0.10(Predicted)
Safety Information
MSDS Information
3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- Usage And Synthesis
UsesDHODH-IN-19 is a potent inhibitor of DHODH. DHODH is present in the inner membrane of human mitochondria and is an iron-containing flavin-dependent enzyme. DHODH-IN-19 inhibits tumor growth. DHODH-IN-19 has the potential for the research of cancer and inflammation disease (extracted from patent WO2021238881A1, compound 1)[1].
References[1] Shuhui Chen, et al. Triazolones. Patent WO2021238881A1.
3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)- Preparation Products And Raw materials
Tag:3H-1,2,4-Triazol-3-one, 2-[4-[2-(2-chloro-6-fluorophenyl)-1-fluoroethenyl]-2-fluoro-5-[(1S)-2,2,2-trifluoro-1-methylethoxy]phenyl]-4-ethyl-2,4-dihydro-5-(hydroxymethyl)-(2742675-85-8) Related Product Information
Brequinar Oxaliplatin Capecitabine Gemcitabine Folic acid ANISOMYCIN